Who Owns TVRD?

Tvardi Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$3.04

-0.06 (-1.94%)

Market Cap

$37.3M

Shares Outstanding

9,381,344

Institutional Holders

34

Total Inst. Value

$4.3M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1JONES FINANCIAL COMPANIES LLLP$1.1M8,228
2VANGUARD GROUP INC$852K168,101
3FARALLON CAPITAL MANAGEMENT LLC$658K129,685
4RENAISSANCE TECHNOLOGIES LLC$449K88,530
5BlackRock, Inc.$314K61,869
6TWO SIGMA ADVISERS, LP$249K49,180
7GEODE CAPITAL MANAGEMENT, LLC$199K39,366
8BANK OF AMERICA CORP /DE/$136K27,046
9UBS Group AG$97K19,101
10MILLENNIUM MANAGEMENT LLC$88K17,420

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold TVRD?

As of Q1 2025, 34 institutional investors report holding TVRD (Tvardi Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most TVRD?

The largest institutional holder of TVRD is JONES FINANCIAL COMPANIES LLLP with $1.1M in shares.

Are institutions buying or selling TVRD?

This quarter, 4 institutions opened new positions in TVRD and 13 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.